Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Semin Perinatol. 2013 Apr;37(2):60–68. doi: 10.1053/j.semperi.2013.01.001

Progress in Understanding the Pathogenesis of BPD Using the Sheep and Baboon Models

Kurt H Albertine 1
PMCID: PMC3664547  NIHMSID: NIHMS453365  PMID: 23582959

Introduction

About half a million infants are born preterm in the US each year. Of these preterm infants, about 30,000 will develop respiratory failure (respiratory distress syndrome, RDS) that requires endotracheal intubation and mechanical ventilation with oxygen-rich gas. Respiratory failure is most frequently related to structural and functional immaturity of the lung that interferes with efficient gas exchange. Consequently, endotracheal intubation and mechanical ventilation with oxygen-rich gas are necessary for life. About half of preterm infants with RDS will require prolonged mechanical ventilation support and go on to develop bronchopulmonary dysplasia (BPD; also called neonatal chronic lung disease). Similar to RDS, risk for BPD is related to gestational age.1 While BPD is a multifactorial disease, the common antecedents are prematurity and mechanical ventilation with oxygen-rich gas.

BPD, defined by oxygen requirement at 36 weeks corrected gestational age is among the most common chronic lung diseases in infants in the US. Over the past 2 decades, use of antenatal steroids to accelerate lung maturation, postnatal surfactant to reduce surface tension and therefore increase lung recruitment, and gentler ventilator support to reduce ventilator-induced lung injury has shifted BPD to more and more immature preterm infants.29 Nonetheless, high rates of BPD persist.1012

Respiratory failure secondary to BPD is mainly related to lung immaturity.13 Lung immaturity leads to persistently poor respiratory gas exchange. In addition, BPD leads to increased abundance of smooth muscle in the wall of pulmonary arterioles and bronchioles, as well as increased tone and reactivity.1417 These structural and functional modifications of arterioles and bronchioles in the lung lead to pulmonary hypertension and excess airway expiratory resistance, respectively 1822 The causes of these pathological and pathophysiological features of BPD are incompletely understood. Effective prevention or therapy is unavailable. Ominously, the consequences of BPD may be life-long.23

This review is organized into five sections. The first three sections deal with the pathogenesis of poor respiratory gas exchange, pulmonary hypertension, and excess airway expiratory resistance, respectively. Each section starts with the primary result from a recently published clinical study. Structural and functional insights are summarized from studies using the experimental large animal models of evolving neonatal chronic lung disease: chronically ventilated preterm baboons and preterm lambs. Both models recapitulate the clinical setting of preterm birth and respiratory failure that require prolonged ventilation support with oxygen-rich gas. The fourth section focuses on a gentler, non-invasive ventilation strategy (nasal continuous positive airway pressure; nasal CPAP). The final section presents our epigenetic hypothesis for the pathogenesis of BPD.

Pathogenesis of Poor Respiratory Gas Exchange

A recently published human clinical study shows that carbon monoxide diffusing capacity is lower among former preterm infants with BPD than control infants who were born at term gestation and were healthy.24 This is a worrisome outcome.2527 How does it come about? Part of the answer comes from understanding the process by which the normal diffusion (alveolar wall) barrier is formed.

In the fully developed human lung, the diffusion barrier encountered by oxygen and carbon dioxide is thin (~1.5 μm).2830 The essential structural elements are alveolar epithelium, composite elements making up the alveolar wall, and the alveolar endothelium. These elements are encountered by oxygen and carbon dioxide as they diffuse along their respective concentration gradients. By comparison, during the second half of gestation, the wall barrier is many micrometers in thickness during the canalicular stage of lung development (weeks 16 to 26 of gestation) and saccular stage of lung development (weeks 24 to 38 of gestation).31 The predominant contributor to wall thickness is mesenchyme. Added thickness is contributed by cuboidal epithelial cells that line the immature airspaces during the canalicular and saccular stages of lung development. Moreover, during both stages of lung development, capillaries are distant from the immature airspaces. The combined thickness of the mesenchyme and distant location of capillaries in the preterm infant’s immature lung parenchyma make a substantial anatomic barrier to diffusion of oxygen and carbon dioxide. A functional impediment to diffusion of oxygen and carbon dioxide is water because solubility of gas is much lower in water than air. Thus, the thicker and wetter parenchyma, and wetter airspaces in the lung of preterm infants reduces diffusion of oxygen and carbon dioxide compared to the thinner and drier environment of the mature lung.

An approach to identify underlying mechanisms that lead to BPD is to reproduce BPD in animal models.32 Only two animal models use chronically ventilated preterm neonates: the preterm baboon model 3339 and the preterm lamb model.4047 The preterm baboon program ended almost a decade ago, however, leaving the preterm lamb model as the only large-animal, physiological model of neonatal chronic lung disease. Advantage of both models is that they reproduce the clinical setting of preterm birth, respiratory failure, and prolonged ventilation support with oxygen-rich gas for days or weeks. Advantages of the preterm baboon model were the close phylogeny of baboons (primates) to humans and the preterm baboons were more immature (~67% of gestation) than preterm lambs (~75% gestation). An advantage of the preterm lamb model is that the fetal lambs are larger (~3 Kg body wt; ~10-fold the size of fetal baboons) and therefore more amenable to physiological studies and repeated blood sampling. Disadvantages of both models are that they are expensive and require 24-hour care.

The lung histopathology of evolving neonatal chronic lung disease in the preterm baboon and preterm lamb models recapitulates that which occurs in preterm infants with BPD.13,19,22,48 Specifically, histopathological characteristics in chronically ventilated preterm baboons and preterm lambs include alveolar simplification, persistent muscularization of pulmonary arterioles, and increased muscularization of bronchioles.3336,4044,49

Alveolar simplification results from failure of alveolar secondary septa to sprout or from stunted growth from the walls of saccules.50 Without outgrowth of secondary septa, the saccules are not divided into anatomic alveoli.31 Without division, airspace surface area for gas exchange is small. Stunted growth also reduces gas exchange surface area, a point that will be returned to later in this section.

An important extracellular matrix player in alveolar secondary septal formation is elastin. This is revealed through use of knock-out (null) mice constructs. For example, simplified distal airspaces typify the histological appearance of the lungs of mice that lack platelet-derived growth factor-A.51 Some of the mice survive through the early postnatal period but their lungs lack both elastin and myofibroblasts. Further evidence is provided by elastin knock-out (null) mice.52 Elastin-null mice survive through the first several days of postnatal life, but they are cyanotic. Their lungs, which lack elastin, have distal airspaces that are arrested at the saccular stage of lung development. Interestingly, their lungs also have fewer vascular and airway generations, suggesting that elastin also is associated with vascular and airway growth in the developing lung.

The lungs of chronically ventilated preterm baboons and preterm lambs with evolving neonatal chronic lung disease have aberrant and continuously upregulated synthesis and secretion of elastin.40 Upregulated synthesis occurs quickly, by the third day of continuous mechanical ventilation. Increased secretion of elastin results in increased abundance of elastin fibers that accumulate within the walls lining the immature airspaces.40,41 The accumulated elastin fibers form dense bundles in the walls. Also, and particularly conspicuously, the excessive and aberrant accumulation of elastin fibers occurs across the width and height of stunted secondary septa.

Another important player in alveolar secondary septal formation is capillary growth. Normally, growth increases the number and surface area of capillaries in the mesenchyme.53,54 However, the growing capillaries are distant from the cuboidal epithelial cells that line the airspaces during the canalicular stage of lung development. During the saccular and alveolar stages of lung development, capillary growth continues in the walls that line the saccules and forming alveoli. In addition, capillaries grow into the mesenchymal core of alveolar secondary septa as the latter form and lengthen. Preterm birth and prolonged mechanical ventilation reduce capillary growth in the lung of preterm baboons 55 and preterm lambs.41,43,47 Studies using preterm lambs also show that the stunted alveolar secondary septa lack capillaries47. Therefore, the secondary septa cannot contribute to the surface area of the air:blood barrier that participates in respiratory gas exchange. Another consequence of prolonged mechanical ventilation of preterm lambs is fewer pre- and post-capillary arterioles and venules.41,43 Thus, growth of the pulmonary microvascular bed is reduced. This contributes to the respiratory failure seen in these animal models.

The histopathology of neonatal chronic lung disease also includes persistently thick, cellular distal airspace walls. Normally, remodeling occurs during lung development such that loss of mesenchymal cells contributes to thinning of the future alveolar walls. We showed, using preterm lambs, that mechanical ventilation for 3 days leads to less apoptosis of mesenchymal cells.46 Not only is apoptosis lower, concomitantly, proliferation of mesenchymal cells is higher. Both effects on mesenchymal cells continue in the lung of preterm lambs that are mechanically ventilated for 3 weeks (unpublished data). Consequently, the distal airspace walls remain thick and more cellular, which also contribute to alveolar simplification.

A treatment that improves outcomes among some chronically ventilated preterm infants is vitamin A supplementation. The rationale for vitamin A supplementation is preterm infants is that they are deficient in retinol.5659 Large multi-center studies show that vitamin A supplementation reduces the need for oxygen at 36 weeks postmenstrual age in subgroups of preterm infants at risk of BPD.6062 An important note, however, is that not all human clinical studies have shown benefit of vitamin A supplementation.

Results from preterm baboons and preterm lambs given supplemental vitamin A daily also are inconsistent. Supplemental vitamin A (Aquasol; 5,000 U/Kg/d) given to mechanically ventilated preterm baboons for 14 days did not improve ventilation or oxygenation, did not promote alveolar formation or alveolar capillary growth, and did not increase expression of vascular growth factors.63 That study calls into question the hypothesis that vitamin A supplementation is beneficial. However, the experimental design was short (14 days) and therefore may have been inadequate to allow the growth-promoting effects of vitamin A. Supporting the latter explanation are results of vitamin A supplementation (Aquasol; 5,000 U/Kg/d) to mechanically ventilated preterm lambs for 21 days.47 Alveolar formation, alveolar capillary growth, and expression of vascular growth factors were greater in the treated group of preterm lambs compared to untreated preterm lambs. In contrast, expression and accumulation of elastin was less in the lung of the vitamin A-treated group. These structural and molecular improvements are associated with better respiratory gas exchange, although the improvement was not statistically significant.

A question remains as to whether the lung parenchyma eventually forms normal surface area for gas exchange in survivors of BPD who are clinically stable. Studies using recovered preterm baboons and preterm lambs show that disruptions in alveolar secondary septation, capillary and microvessel growth, and elastin synthesis and secretion persist later in life. Studies of the lung of preterm baboons showed that mechanical ventilation for 14 days and recovery for 33 weeks led to persistently enlarged airspaces and less parenchyma than control baboons.64 Thirty-three weeks of life for baboons is equivalent to ~2 years of postnatal age for humans. New studies in progress in our laboratory suggest that mechanical ventilation for 3 days and recovery for 12 weeks or 24 weeks leads to persistence of alveolar simplification compared to control lambs born at term that live for 2 months or 5 months, respectively (unpublished results). Twelve weeks of life for sheep is equivalent to ~2 years postnatal age for humans, whereas 24 weeks of life for sheep is equivalent to ~6 years postnatal age for humans. These persistent structural manifestations of preterm birth and mechanical ventilation on alveolar formation provide a structural correlate for lower diffusing capacity among survivors of BPD.24 Long term pulmonary outcomes in human neonates with BPD have been covered in the chapter by Bhandari and McGrath-Morrow in this issue.

Pathogenesis of Pulmonary Hypertension

Pulmonary hypertension also contributes to morbidity and mortality among preterm infants who develop BPD.14,65,66 For example, a recent clinical study shows that ~18% of 145 preterm infants (gestational age 26 weeks) had pulmonary hypertension at any time during hospitalization.67 Pulmonary hypertension in human neonates with BPD has been covered in the chapter by Berkelhamer, Mestan and Steinhorn in this issue.

Common features of pulmonary vascular pathology in preterm infants who died with BPD are thicker smooth muscle walls of pulmonary arterioles, more elastin in the walls of the arterioles, and fewer pulmonary microvessels.18,48,68,69 These pathological features also are evident in the lung of chronically ventilated preterm baboons3336,49 and preterm lambs.4043

A dysregulated molecular pathway that contributes to pulmonary hypertension is nitric oxide (NO) biosynthesis. Results from both preterm baboons70 and preterm lambs42 indicate that the NO biosynthetic pathway becomes progressively downregulated during prolonged mechanical ventilation. The main findings are that prolonged mechanical ventilation leads to less endothelial NO synthase (eNOS) enzyme activity, less eNOS protein abundance, and less guanylate cyclase protein abundance.4042,44,70,71 Soluble guanylate cyclase is an intermediary enzyme through which inhaled NO causes vascular smooth muscle cells to relax. Two cellular sources of eNOS in the lung are vascular endothelial cells and airway epithelial cells. Relevant to the topic of pulmonary hypertension, endothelial cells that line pulmonary arterioles are an important endogenous source of NO.42,44,72 Smooth muscle cells in the wall of pulmonary arterioles are an endogenous source of soluble guanylate cyclase. The topic of airway epithelial cells as a source of NO will be considered in the next section of this review.

Less eNOS enzyme activity, eNOS protein abundance, and soluble guanylate cyclase protein abundance in the lung of chronically ventilated preterm baboons and preterm lambs are associated with thicker smooth muscle walls around pulmonary arterioles.4244,72 These associated changes are related to greater pulmonary vascular resistance. The relationship between NO and increased muscularization of pulmonary arterioles stems from the effect of NO on vascular smooth muscle cells. Nitric oxide inhibits growth of vascular smooth muscle cells, in vitro73,74 and in vivo.75 Furthermore, providing exogenous NO, by inhalation or donor, inhibits vascular smooth muscle growth after injury.7678

Retrospective clinical studies show that inhaled NO improves oxygenation in preterm infants with severe BPD.79 But what remains unclear is whether inhaled NO changes reactivity and structure of pulmonary arterioles in the lung of preterm infants with BPD.

Studies using preterm baboons show that 14 days of continuous inhalation of 5 parts per million (ppm) of NO during mechanical ventilation decreases pulmonary artery pressure in the first two days of life.80 Echocardiographic analysis revealed that left ventricular function is not impaired, even though mean systemic arterial pressure is increased transiently on days of life 5 and 6. Studies using preterm lambs provide additional insights. One insight is that tachyphylaxis to inhaled NO develops during weeks of mechanical ventilation.44 Specifically, at week-of-life 2, pulmonary vascular resistance decreases ~20% in response to 1 hour inhalation of 15 ppm of NO. However, a week later (week-of-life 3), 1 hour of 15 ppm inhaled NO has no effect on pulmonary vascular resistance.

Because relaxation requires intact endothelium and intact vascular smooth muscle, identification of whether one or both cell types become dysfunctional is necessary. Subsequent tests evaluated function of each cell type in the same preterm lambs on the same day that NO was inhaled for 1 hour.44 Tests were separated by recovery periods. A test of vascular endothelial cell function is infusion of acetylcholine to cause endothelial-dependent vasodilation. Pulmonary vascular resistance did not decrease in response to infusion of acetylcholine, indicating dysfunction of pulmonary vascular endothelial cells. This physiologic evidence of pulmonary vascular endothelial cell dysfunction was associated with less eNOS protein. A test for vascular smooth muscle function is infusion of 8-bromo-cyclic guanosine monophosphate (cGMP), which directly relaxes smooth muscle cells. Pulmonary vascular resistance did decrease in the same preterm lambs, indicating normal function of pulmonary vascular smooth muscle cells. Therefore, prolonged mechanical ventilation of preterm lambs leads to dysfunction of endothelial cells in pulmonary arterioles.

The aforementioned results following inhalation of 15 ppm NO for 1 hour by preterm lambs led to a study of continuously inhaled NO for 3 weeks in different group of chronically ventilated preterm lambs.72 The principal results are that continuous inhalation of 5 to 15 ppm NO did not prevent pulmonary hypertension or persistent muscularization of pulmonary arterioles.

An interesting, and unexpected, result occurred in the lung of preterm baboons and preterm lambs that inhaled NO continuously: more advanced alveolar formation.72,80 Among preterm baboons, continuously inhaled NO also improves lung growth relative to body weight by ~20%.80 These effects of continuous inhalation of NO for weeks are likely related, in part, to inhibition of alveolar epithelial cell apoptosis by NO.8183

The results of the preterm baboon and preterm lamb studies provide insights into pathogenic mechanisms leading to pulmonary hypertension in preterm infants who develop BPD.67

Pathogenesis of Excess Airway Expiratory Resistance

A third source for concern about life-long outcomes is that premature infants with BPD have fixed airway disease at 11 years of age compared to class mates.84 Baseline lung function in the survivors is abnormal and bronchodilators are used more. These respiratory morbidities are evident in about 70% of the 11-year-olds who were born preterm and developed BPD. Mechanisms by which persistence occurs in these children remain to be discovered.

Bronchioles during the canalicular and saccular stages of normal human lung development have little smooth muscle in their wall, the epithelium is immature, and cell-cell adhesion is weak. Normally, airway smooth muscle accumulation around bronchioles increases postnatally.31,47 Pathologically, in BPD, bronchioles have accumulation of airway smooth muscle cells in their wall, making wall thickness greater.16,18,19,85

The preterm baboon and preterm lamb models provide insights about the pathogenesis of airway outcomes. The results show that prolonged mechanical ventilation leads to higher peak inspiratory pressure, excess airway expiratory resistance, and lower lung compliance.38,42 Prolonged mechanical ventilation also leads to increased thickness of the smooth muscle wall around bronchioles of preterm lambs.42

Excess airway expiratory resistance and greater thickness of smooth muscle walls around bronchioles are related to low levels of eNOS protein abundance and localization in bronchioles of chronically ventilated preterm lambs.42 Diminished eNOS protein in airway epithelial cells likely contributes to excess airway expiratory resistance because NO derived from airway epithelium regulates bronchomotor tone in the developing lung.86,87 A role for NO in regulation of muscularization of bronchioles is demonstrated by use of NO donors, which inhibit proliferation of human airway smooth muscle cells cultured in vitro.74

Studies using preterm baboons and preterm lambs also reveal that continuous inhalation of NO reduces airway expiratory resistance.72,80 In addition, continuously inhaled NO reduces the thickness of the smooth muscle wall of bronchioles in preterm lambs.72 Thinner airway smooth muscle walls of bronchioles surprised us because the adjacent pulmonary arterioles had persistently thick smooth muscle walls,72 as described in the previous section. We attributed improvement in airway function and structure to direct exposure of airway smooth muscle cells to inhaled NO. A potential explanation for why the adjacent pulmonary arterioles had persistently thick smooth muscle walls may be related to the longer diffusion distance from the lumen of bronchioles or airspaces that flank vascular smooth muscle cells in the wall of the adjacent pulmonary arterioles.

Our new studies using former mechanically ventilated preterm lambs that are recovered provide some physiological insights about long-term outcomes for the lung’s airways. The insights are that airway hyperreactivity, induced by methacholine challenge, persists at 2 months or 5 months after preterm birth and 3 days of mechanical ventilation (unpublished data). The measured parameters were expiratory tidal volume and airway expiratory resistance. The former preterm lambs that recovered have lower expiratory tidal volume and higher airway expiratory resistance than normal lambs when challenged with methacholine. We have not measured smooth muscle accumulation in bronchioles so whether increased muscularization persists remains to be determined. Structural results will be important from a translational perspective to better understand the basis of abnormal baseline lung function and increased use of bronchodilators among 11-year-olds who were born preterm and developed BPD.84

Gentler, non-invasive ventilation

An encouraging observation is that the incidence of BPD is lower in preterm infants who are managed by nasal continuous positive airway pressure (nasal CPAP), which is non-invasive because endotracheal intubation is not used.88 The causes of this difference remain incompletely understood. Emerging differences between nasal CPAP and mechanical ventilation include inflammation, alveolar formation, and alveolar capillary growth. Inflammation is less with nasal CPAP because fewer neutrophils and less hydrogen peroxide are retrieved in alveolar fluid at 2 hours of bubble nasal CPAP compared to 2 hours of mechanical ventilation.89 Alveolar formation and alveolar capillary growth are greater with nasal CPAP than mechanical ventilation. These desirable outcomes occur in preterm baboons at 28 days of nasal CPAP compared to mechanical ventilation.90 They also occur in preterm lambs at 3 days46 or 21 days (unpublished results) of nasal high-frequency ventilation (nasal HFV) compared to mechanical ventilation. We use nasal HFV for prolonged ventilation of preterm lambs because their anatomic dead space is large (long snout and neck compared to humans). We tried bubble nasal CPAP; however, arterial carbon dioxide in blood progressively increased, whereas pH progressively decreased, to unphysiological levels within 3 to 4 hours. Retention of carbon dioxide and respiratory acidosis did not occur when high-frequency flow interruption was used (Percussionaire ventilator). Another advantage of nasal HFV was upregulation of vascular growth factors in the lung. A novel finding is that thinning of the distal airspace walls occurs during nasal HFV compared to mechanical ventilation. Thinning is related to more apoptosis, and less proliferation, of mesenchymal cells in the lung. Together, these results from chronically ventilated preterm baboons and preterm lambs provide important mechanistic insights regarding the beneficial effects of gentler, non-invasive ventilation on pulmonary outcomes. Information about the use of nasal ventilation in human premature neonates at risk for BPD has been provided in the chapter by Bhandari in this issue.

Epigenetic Hypothesis for the Molecular Basis of BPD

We focus on epigenetic regulation of gene expression because epigenetics provides a molecular mechanism for adjustment of gene expression in response to environmental changes.91 For BPD, initial environmental changes include preterm birth, mechanical ventilation, and exposure to oxygen-rich gas.

Epigenetic regulation of gene expression involves modifications to chromatin. The fundamental unit of chromatin is the nucleosome. A nucleosome has 146 base pairs of DNA that wrap around a core of histone proteins.92 The modifications to chromatin are a code for regulating gene expression. Regulation facilitates or interferes with interactions between transcription complexes and DNA. The regulatory interactions are dynamic and therefore adjust over time, including life-long.

Epigenetic regulating mechanisms include histone modifications, DNA methylation, microRNAs, and nucleosome positioning.93,94 Histone modifications participate in regulation of initiation, elongation, and/or termination of transcription along a gene locus, a topic that will be returned to later in this section. Methylation of DNA happens at sites referred to as CpG: cytosine, linked by phosphate, to guanine. DNA methylation has varied functions, including regulating transcription at transcriptional start sites, at regulatory elements, along a gene locus, and at repeat sequences.95 Another epigenetic regulating mechanism is microRNAs, which are RNA molecules that do not code for a protein. MicroRNAs bind to the 3′ untranslated region of target genes to silence transcription.96 A fourth epigenetic regulating mechanism is nucleosome positioning. Nucleosome positioning is important for exposing or not exposing transcription start sites to transcription complexes and RNA polymerase. Understanding how these epigenetic mechanisms influence development of BPD remains to be done.

A research question that our group is addressing is why, at the molecular level, is the incidence of BPD apparently lower among preterm infants who are managed by nasal CPAP compared to mechanical ventilation.88 Our preterm lamb model provides unique opportunities to test mechanistic hypotheses. One of our hypotheses tests genome-wide epigenetic characteristics in the lung of preterm lambs managed by nasal HFV compared to mechanical ventilation.46 An intriguing new observation is that nasal HFV leads to genome-wide hyperacetylation of histones in the lung. Mechanical ventilation, by comparison, leads to genome-wide hypoacetylation of histones in the lung. These observations suggest that ventilation mode results in unique epigenetic modifications.

A limitation of our genome-wide epigenetic observations is that they do not identify epigenetic effects on a specific gene involved in alveolar formation, capillary growth, or elastin synthesis and secretion. Therefore, another of our hypotheses focuses on insulin-like growth factor -1 (IGF-1) because IGF-1 directs lung development normally,97 IGF-1 expression in the lung is increased in RDS and BPD,98 and IGF-1 expression is epigenetically regulated.91,99

Our newest results using chronically ventilated preterm lambs suggest that IGF-1 expression is higher in the lung of mechanically ventilated preterm lambs compared to those supported by nasal HFV. We are beginning to examine why the two ventilation modes have different effects on IGF-1 expression in the lung. We chose to start with the histone code along the IGF-1 gene locus because the histone code contributes to regulation of gene transcription.91,99,100 The histone code is the pattern of histone modifications along the full length of a gene locus. Increased expression may occur because of increased initiation of transcription, altered elongation of transcription, and/or altered termination of transcription. Our initial results suggest that the histone code for IGF-1 is scrambled in the lung when preterm lambs are managed by mechanical ventilation compared to nasal HFV. At this time, we do not know the meaning of the scrambled histone code on increased IGF-1 expression in the lung. However, a hypothesis that we are testing is that ventilation leads to promiscuous initiation of transcription. We are testing the possibility that ventilation leads to exposure of multiple transcription start sites for IGF-1. Interestingly, fetal lambs that are not allowed to breathe have only one transcription start site for IGF-1 that is accessible. These initial results are intriguing but explore only one of the potential epigenetic mechanisms by which the histone code regulates IGF-1 expression.

Summary

Improved survival of preterm infants who developed BPD is becoming increasingly important because of the high risk for persistent pulmonary morbidities such as poor respiratory gas exchange, pulmonary hypertension, and excess airway expiratory resistance later in life. These are ominous long-term outcomes that have important implications about quality of life. Secondarily, the long-term outcomes also lead to life-long health care costs. This review focused on unique insights provided by the two large-animal, physiological models of neonatal chronic lung disease: preterm baboons and preterm lambs. Both models recapitulate the clinical setting of preterm birth and respiratory failure that require prolonged ventilation support. The models show pathologic and pathophysiologic manifestations of alveolar simplification, reduced capillary growth, and aberrant accumulation of elastin fibers during the evolution of neonatal chronic lung disease, as well as persistence of alveolar simplification later in life. The latter finding correlates with lower diffusing capacity among survivors of BPD.24 Both models also show that pulmonary arterioles have thicker smooth muscle walls and more elastin in the thickened walls, as well as fewer microvessels. These pathologic features are associated with pulmonary hypertension, which is a life-long concern for preterm infants who develop BPD.67 Another contribution of both models is that prolonged mechanical ventilation leads to increased abundance of smooth muscle cells in bronchioles, a finding that is associated with excess airway expiratory resistance that persists later in life. This association between pathology and pathophysiology in chronically ventilated preterm lambs correlates with persistent abnormal lung function and increased use of bronchodilators at 11 years of age among survivors of BPD.84

The preterm baboon and preterm lamb models also reveal that the NO biosynthetic pathway becomes progressively downregulated during prolonged mechanical ventilation. Furthermore, both models show that physiological responsiveness to inhaled NO progressively declines because of endothelial cell dysfunction. Two surprising results surfaced along the way. Surprisingly, alveolar formation is better. This unexpected beneficial effect may be related to paracrine signaling by NO to upregulate expression of growth factors, such as vascular growth factors.101 Unexpectedly, continuous inhalation of NO decreases abundance of airway smooth muscle cells in the wall of bronchioles of preterm lambs. In the same treated preterm lambs, abundance of pulmonary vascular smooth muscle cells remained greater, suggesting that inhaled NO diffusion to vascular smooth muscle cells in the wall of pulmonary arterioles may be interrupted during prolonged mechanical ventilation.

Other insights on pulmonary outcomes provided by chronically ventilated preterm baboons and preterm lambs are related to the beneficial effects of gentler, non-invasive ventilation compared to mechanical ventilation. Nasal CPAP (preterm baboons) and nasal HFV (preterm lambs) lead to appropriate alveolar formation, alveolar capillary growth, and expression of elastin and growth factors. Finally, new observations using preterm lambs suggest that ventilation mode results in different epigenetic modifications to histones that are both genome-wide and gene-specific in the lung. As we refine the epigenetic observations, the new results may open doors to potential treatment approaches to minimize the consequences of BPD and its long-term effects.

Acknowledgments

Portions of this work were supported by NIH grants HL110002 and HL062875

Appreciation is expressed to Dr. Ronald S. Bloom and Dr. Lisa Joss-Moore for thoughtful input for this review. The studies of chronically ventilated preterm lambs could not be done without the dedicated contributions of Mar Janna Dahl and numerous technicians, medical students, and undergraduate students.

Footnotes

Dr. Albertine has no conflicts of interest to disclose.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126:443–456. doi: 10.1542/peds.2009-2959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kendig JW, Notter RH, Cox C, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks’ gestation. N Engl J Med. 1991;324:865–871. doi: 10.1056/NEJM199103283241301. [DOI] [PubMed] [Google Scholar]
  • 3.Angus DC, Linde-Zwirble WT, Clermont G, et al. Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med. 2001;164:1154–1160. doi: 10.1164/ajrccm.164.7.2012126. [DOI] [PubMed] [Google Scholar]
  • 4.Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics. 2001;107:e1. doi: 10.1542/peds.107.1.e1. [DOI] [PubMed] [Google Scholar]
  • 5.Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: The experience of the NICHD neonatal research network. Pediatrics. 2002;110:285–291. doi: 10.1542/peds.110.2.285. [DOI] [PubMed] [Google Scholar]
  • 6.Allen J, Zwerdling R, Ehrenkranz R, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med. 2003;168:356–396. doi: 10.1164/rccm.168.3.356. [DOI] [PubMed] [Google Scholar]
  • 7.Tucker J, McGuire W. Epidemiology of preterm birth. Br Med J (Clin Res Ed) 2004;329:675–678. doi: 10.1136/bmj.329.7467.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946–1955. doi: 10.1056/NEJMra067279. [DOI] [PubMed] [Google Scholar]
  • 9.Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2005. Natl Vital Stat Rep. 2007;56:1–103. [PubMed] [Google Scholar]
  • 10.Wilson-Costello D, Friedman H, Minich N, et al. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics. 2005;115:997–1003. doi: 10.1542/peds.2004-0221. [DOI] [PubMed] [Google Scholar]
  • 11.Field DJ, Dorling JS, Manktelow BN, et al. Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994–9 compared with 2000–5. Br Med J (Clin Res Ed) 2008;336:1221–1223. doi: 10.1136/bmj.39555.670718.BE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371:261–269. doi: 10.1016/S0140-6736(08)60136-1. [DOI] [PubMed] [Google Scholar]
  • 13.Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:179–184. doi: 10.1053/j.semperi.2006.05.004. [DOI] [PubMed] [Google Scholar]
  • 14.Berman W, Jr, Yabek SM, Dillon T, et al. Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. Pediatrics. 1982;70:708–712. [PubMed] [Google Scholar]
  • 15.Motoyama EK, Fort MD, Klesh KW, et al. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. Am Rev Respir Dis. 1987;136:50–57. doi: 10.1164/ajrccm/136.1.50. [DOI] [PubMed] [Google Scholar]
  • 16.Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am. 1994;41:277–315. doi: 10.1016/s0031-3955(16)38726-0. [DOI] [PubMed] [Google Scholar]
  • 17.Gerhardt T, Hehre D, Feller R, et al. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr. 1987;110:448–456. doi: 10.1016/s0022-3476(87)80516-4. [DOI] [PubMed] [Google Scholar]
  • 18.Hislop AA, Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol. 1990;9:152–161. doi: 10.1002/ppul.1950090306. [DOI] [PubMed] [Google Scholar]
  • 19.Margraf LR, Tomashefski JF, Jr, Bruce MC, et al. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis. 1991;143:391–400. doi: 10.1164/ajrccm/143.2.391. [DOI] [PubMed] [Google Scholar]
  • 20.Van Lierde S, Cornelis A, Devlieger H, et al. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? A clinicopathologic study. Biol Neonate. 1991;60:152–162. doi: 10.1159/000243402. [DOI] [PubMed] [Google Scholar]
  • 21.Sward-Comunelli SL, Mabry SM, Truog WE, et al. Airway muscle in preterm infants: changes during development. J Pediatr. 1997;130:570–576. doi: 10.1016/s0022-3476(97)70241-5. [DOI] [PubMed] [Google Scholar]
  • 22.Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29:710–717. doi: 10.1016/s0046-8177(98)90280-5. [DOI] [PubMed] [Google Scholar]
  • 23.Northway WH., Jr Bronchopulmonary dysplasia: thirty-three years later. Pediatr Pulmonol. 2001;23:5–7. [PubMed] [Google Scholar]
  • 24.Balinotti JE, Chakr VC, Tiller C, et al. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am J Respir Crit Care Med. 2010;181:1093–1097. doi: 10.1164/rccm.200908-1190OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Northway HW, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med. 1990;323:1793–1799. doi: 10.1056/NEJM199012273232603. [DOI] [PubMed] [Google Scholar]
  • 26.Northway WH. Bronchopulmonary dysplasia - 25 years later. Pediatrics. 1992;89:969–973. [PubMed] [Google Scholar]
  • 27.Bhutani VK, Abbasi S. Long-term pulmonary consequences in survivors with bronchopulmonary dysplasia. Clin Perinatol. 1992;19:649–671. [PubMed] [Google Scholar]
  • 28.Weibel ER. Morphometry of the Lung. Vol. 63. New York: Academic Press; 1963. pp. 78–82. [Google Scholar]
  • 29.Crapo JD, Young SL, Fram EK, et al. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis. 1983;128:S42–46. doi: 10.1164/arrd.1983.128.2P2.S42. [DOI] [PubMed] [Google Scholar]
  • 30.Albertine KH. Anatomy of the lungs. In: Mason RJ, Broaddus VC, Martin TR, King JTE, Schraufnagel DE, Murray JF, Nadel JA, editors. Murray & Nadel’s Textbook of Respiratory Medicine. 5. Phila, WB: Saunders/Elsevier; 2010. pp. 3–25. [Google Scholar]
  • 31.Albertine KH, Pysher TJ. Impaired lung growth after injury in premature lung. In: Polin RA, Fox WW, Abman S, editors. Fetal and Neonatal Physiology. 4. NY: Elsevier Sciences; 2011. pp. 1039–1047. [Google Scholar]
  • 32.Albertine KH. Aiding Ill infants. International Innovations. 2009:33–35. [Google Scholar]
  • 33.Escobedo MB, Hilliard JL, Smith F, et al. A baboon model of bronchopulmonary dysplasia. I. Clinical features. Exp Mol Pathol. 1982;37:323–334. doi: 10.1016/0014-4800(82)90045-4. [DOI] [PubMed] [Google Scholar]
  • 34.Coalson JJ, Kuehl TJ, Escobedo MB, et al. A baboon model of bronchopulmonary dysplasia. II. Pathologic features. Exp Mol Pathol. 1982;37:335–350. doi: 10.1016/0014-4800(82)90046-6. [DOI] [PubMed] [Google Scholar]
  • 35.Coalson JJ, Winter VT, Gerstmann DR, et al. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis. 1992;145:872–881. doi: 10.1164/ajrccm/145.4_Pt_1.872. [DOI] [PubMed] [Google Scholar]
  • 36.deLemos RA, Coalson JJ. The contribution of experimental models to our understanding of the pathogenesis and treatment of bronchopulmonary dysplasia. Clin Perinatol. 1992;19:521–539. [PubMed] [Google Scholar]
  • 37.Coalson JJ, Winter VT, Siler-Khodr T, et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med. 1999;160:1333–1346. doi: 10.1164/ajrccm.160.4.9810071. [DOI] [PubMed] [Google Scholar]
  • 38.Yoder BA, Siler-Khodr T, Winter VT, et al. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med. 2000;162:1867–1876. doi: 10.1164/ajrccm.162.5.9912145. [DOI] [PubMed] [Google Scholar]
  • 39.McGreal EP, Chakraborty M, Winter VT, et al. Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilation. Neonatology. 2011;100:130–138. doi: 10.1159/000322148. [DOI] [PubMed] [Google Scholar]
  • 40.Pierce RA, Albertine KH, Starcher BC, et al. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol Lung Cell Mol Physiol. 1997;272:L452–L460. doi: 10.1152/ajplung.1997.272.3.L452. [DOI] [PubMed] [Google Scholar]
  • 41.Albertine KH, Jones GP, Starcher BC, et al. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med. 1999;159:945–958. doi: 10.1164/ajrccm.159.3.9804027. [DOI] [PubMed] [Google Scholar]
  • 42.MacRitchie AN, Albertine KH, Sun J, et al. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1011–L1020. doi: 10.1152/ajplung.2001.281.4.L1011. [DOI] [PubMed] [Google Scholar]
  • 43.Bland RD, Albertine KH, Carlton DP, et al. Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res. 2000;48:64–74. doi: 10.1203/00006450-200007000-00013. [DOI] [PubMed] [Google Scholar]
  • 44.Bland RD, Ling CY, Albertine KH, et al. Pulmonary vascular dysfunction in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2003;285:L76–L85. doi: 10.1152/ajplung.00395.2002. [DOI] [PubMed] [Google Scholar]
  • 45.Bland RD, Xu L, Ertsey R, et al. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1370–L1384. doi: 10.1152/ajplung.00367.2006. [DOI] [PubMed] [Google Scholar]
  • 46.Reyburn B, Li M, Metcalfe DB, et al. Nasal ventilation alters mesenchymal cell turnover and improves alveolarization in preterm lambs. Am J Respir Crit Care Med. 2008;178:407–418. doi: 10.1164/rccm.200802-359OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Albertine KH, Dahl MJ, Gonzales LW, et al. Chronic lung disease in preterm lambs: effect of daily vitamin A treatment on alveolarization. Am J Physiol Lung Cell Mol Physiol. 2010;299:L59–L72. doi: 10.1152/ajplung.00380.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Stocker JT. Pathologic features of long-standing “healed” bronchopulmonary dysplasia: a study of 28 3- to 40-month-old infants. Hum Pathol. 1986;17:943–961. doi: 10.1016/s0046-8177(86)80646-3. [DOI] [PubMed] [Google Scholar]
  • 49.Coalson JJ, Kuehl TJ, Prihoda TJ, et al. Diffuse alveolar damage in the evolution of bronchopulmonary dysplasia in the baboon. Pediatr Res. 1988;24:357–366. doi: 10.1203/00006450-198809000-00017. [DOI] [PubMed] [Google Scholar]
  • 50.Burri PH. Structural aspects of prenatal and postnatal development and growth of the lung. In: McDonald JA, editor. Lung Growth and Development. NY: Marcel Dekker, Inc; 1997. pp. 1–35. [Google Scholar]
  • 51.Lindahl P, Karlsson L, Hellstrom M, et al. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development. 1997;124:3943–3953. doi: 10.1242/dev.124.20.3943. [DOI] [PubMed] [Google Scholar]
  • 52.Wendel DP, Taylor DG, Albertine KH, et al. Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol. 2000;23:320–326. doi: 10.1165/ajrcmb.23.3.3906. [DOI] [PubMed] [Google Scholar]
  • 53.Burri PH. Fetal and postnatal development of the lung. Annu Rev Physiol. 1984;46:617–628. doi: 10.1146/annurev.ph.46.030184.003153. [DOI] [PubMed] [Google Scholar]
  • 54.Schachtner SK, Wang Y, Baldwin HS. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. Am J Respir Cell Mol Biol. 2000;22:157–165. doi: 10.1165/ajrcmb.22.2.3766. [DOI] [PubMed] [Google Scholar]
  • 55.Maniscalco WM, Watkins RH, Pryhuber GS, et al. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol. 2002;282:L811–L823. doi: 10.1152/ajplung.00325.2001. [DOI] [PubMed] [Google Scholar]
  • 56.Brandt RB, Mueller DG, Schroeder JR, et al. Serum vitamin A in premature and term neonates. J Pediatr. 1978;92:101–104. doi: 10.1016/s0022-3476(78)80086-9. [DOI] [PubMed] [Google Scholar]
  • 57.Hustead VA, Gutcher GR, Anderson SA, et al. Relationship of vitamin A (retinol) status to lung disease in the preterm infant. J Pediatr. 1984;105:610–615. doi: 10.1016/s0022-3476(84)80432-1. [DOI] [PubMed] [Google Scholar]
  • 58.Shenai JP, Chytil F, Stahlman MT. Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res. 1985;19:185–188. doi: 10.1203/00006450-198502000-00007. [DOI] [PubMed] [Google Scholar]
  • 59.Shenai JP, Chytil F. Vitamin A storage in lungs during perinatal development in the rat. Biol Neonate. 1990;57:126–132. doi: 10.1159/000243172. [DOI] [PubMed] [Google Scholar]
  • 60.Ambalavanan N, Tyson JE, Kennedy KA, et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics. 2005;115:e249–e254. doi: 10.1542/peds.2004-1812. [DOI] [PubMed] [Google Scholar]
  • 61.Tyson JE, Ehrenkranz RA, Stoll BJ, et al. Vitamin (Vit.) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: A 14-center randomized trial. Pediatr Res. 1998;43:199A. [Google Scholar]
  • 62.Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 1999;340:1962–1968. doi: 10.1056/NEJM199906243402505. [DOI] [PubMed] [Google Scholar]
  • 63.Pierce RA, Joyce B, Officer S, et al. Retinoids increase lung elastin expression but fail to alter morphology or angiogenesis genes in premature ventilated baboons. Pediatr Res. 2007;61:703–709. doi: 10.1203/pdr.0b013e318053661d. [DOI] [PubMed] [Google Scholar]
  • 64.Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 1995;152:640–646. doi: 10.1164/ajrccm.152.2.7633720. [DOI] [PubMed] [Google Scholar]
  • 65.Abman SH, Wolfe RR, Accurso FJ, et al. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics. 1985;75:80–84. [PubMed] [Google Scholar]
  • 66.Bush A, Busst CM, Knight WB, et al. Changes in pulmonary circulation in severe bronchopulmonary dysplasia. Arch Dis Child. 1990;65:739–745. doi: 10.1136/adc.65.7.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Bhat R, Salas AA, Foster C, et al. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics. 2012;129:e682–e689. doi: 10.1542/peds.2011-1827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Tomashefski JF, Jr, Oppermann HC, Vawter GF, et al. Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol. 1984;2:469–487. doi: 10.3109/15513818409025895. [DOI] [PubMed] [Google Scholar]
  • 69.Coalson JJ. Pathology of chronic lung disease of early infancy. In: Bland RD, Coalson JJ, editors. Chronic Lung Disease in Early Infancy. NY: Marcel Dekker; 2000. pp. 85–124. [Google Scholar]
  • 70.Afshar S, Gibson LL, Yuhanna IS, et al. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2003;284:L749–L758. doi: 10.1152/ajplung.00334.2002. [DOI] [PubMed] [Google Scholar]
  • 71.Shaul PW, Afshar S, Gibson LL, et al. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol. 2002;283:L1192–L1199. doi: 10.1152/ajplung.00112.2002. [DOI] [PubMed] [Google Scholar]
  • 72.Bland RD, Albertine KH, Carlton DP, et al. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med. 2005;172:899–906. doi: 10.1164/rccm.200503-384OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Thomae KR, Nakayama DK, Billiar TR, et al. The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. J Surg Res. 1995;59:337–343. doi: 10.1006/jsre.1995.1173. [DOI] [PubMed] [Google Scholar]
  • 74.Hamad AM, Johnson SR, Knox AJ. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 1999;277:L910–L918. doi: 10.1152/ajplung.1999.277.5.L910. [DOI] [PubMed] [Google Scholar]
  • 75.Rudic RD, Shesely EG, Maeda N, et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest. 1998;101:731–736. doi: 10.1172/JCI1699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Guo JP, Panday MM, Consigny PM, et al. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol. 1995;269:H1122–H1131. doi: 10.1152/ajpheart.1995.269.3.H1122. [DOI] [PubMed] [Google Scholar]
  • 77.Seki J, Nishio M, Kato Y, et al. FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Atherosclerosis. 1995;117:97–106. doi: 10.1016/0021-9150(95)05563-c. [DOI] [PubMed] [Google Scholar]
  • 78.Lee JS, Adrie C, Jacob HJ, et al. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res. 1996;78:337–342. doi: 10.1161/01.res.78.2.337. [DOI] [PubMed] [Google Scholar]
  • 79.Banks BA, Seri I, Ischiropoulos H, et al. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics. 1999;103:610–618. doi: 10.1542/peds.103.3.610. [DOI] [PubMed] [Google Scholar]
  • 80.McCurnin DC, Pierce RA, Chang LY, et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2005;288:L450–L459. doi: 10.1152/ajplung.00347.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Howlett CE, Hutchison JS, Veinot JP, et al. Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. Am J Physiol. 1999;277:L596–L605. doi: 10.1152/ajplung.1999.277.3.L596. [DOI] [PubMed] [Google Scholar]
  • 82.Wingrove JA, O’Farrell PH. Nitric oxide contributes to behavioral, cellular, and developmental responses to low oxygen in Drosophila. Cell. 1999;98:105–114. doi: 10.1016/S0092-8674(00)80610-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Edwards YS, Sutherland LM, Murray AW. NO protects alveolar type II cells from stretch-induced apoptosis. A novel role for macrophages in the lung. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1236–L1242. doi: 10.1152/ajplung.2000.279.6.L1236. [DOI] [PubMed] [Google Scholar]
  • 84.Fawke J, Lum S, Kirkby J, et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med. 2010;182:237–245. doi: 10.1164/rccm.200912-1806OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003;8:73–81. doi: 10.1016/s1084-2756(02)00193-8. [DOI] [PubMed] [Google Scholar]
  • 86.Jakupaj M, Martin RJ, Dreshaj IA, et al. Role of endogenous NO in modulating airway contraction mediated by muscarinic receptors during development. Am J Physiol Lung Cell Mol Physiol. 1997;273:L531–L536. doi: 10.1152/ajplung.1997.273.3.L531. [DOI] [PubMed] [Google Scholar]
  • 87.Potter CF, Dreshaj IA, Haxhiu MA, et al. Effect of exogenous and endogenous nitric oxide on the airway and tissue components of lung resistance in the newborn piglet. Pediatr Res. 1997;41:886–891. doi: 10.1203/00006450-199706000-00014. [DOI] [PubMed] [Google Scholar]
  • 88.Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics. 2000;105:1194–1201. doi: 10.1542/peds.105.6.1194. [DOI] [PubMed] [Google Scholar]
  • 89.Jobe AH, Kramer BW, Moss TJ, et al. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res. 2002;52:387–392. doi: 10.1203/00006450-200209000-00014. [DOI] [PubMed] [Google Scholar]
  • 90.Thomson MA, Yoder BA, Winter VT, et al. Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2004;169:1054–1062. doi: 10.1164/rccm.200309-1276OC. [DOI] [PubMed] [Google Scholar]
  • 91.Joss-Moore LA, Albertine KH, Lane RH. Epigenetics and the developmental origins of lung disease. Mol Genet Metab. 2011;104:61–66. doi: 10.1016/j.ymgme.2011.07.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Luger K, Mader AW, Richmond RK, et al. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997;389:251–260. doi: 10.1038/38444. [DOI] [PubMed] [Google Scholar]
  • 93.Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705. doi: 10.1016/j.cell.2007.02.005. [DOI] [PubMed] [Google Scholar]
  • 94.Roth DM, Balch WE. Modeling general proteostasis: proteome balance in health and disease. Curr Opin Cell Biol. 2011;23:126–134. doi: 10.1016/j.ceb.2010.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13:484–492. doi: 10.1038/nrg3230. [DOI] [PubMed] [Google Scholar]
  • 96.Sato F, Tsuchiya S, Meltzer SJ, et al. MicroRNAs and epigenetics. FEBS J. 2011;278:1598–1609. doi: 10.1111/j.1742-4658.2011.08089.x. [DOI] [PubMed] [Google Scholar]
  • 97.Lallemand AV, Ruocco SM, Joly PM, et al. In vivo localization of the insulin-like growth factors I and II (IGF I and IGF II) gene expression during human lung development. Int J Dev Biol. 1995;39:529–537. [PubMed] [Google Scholar]
  • 98.Chetty A, Andersson S, Lassus P, et al. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol. 2004;37:128–136. doi: 10.1002/ppul.10415. [DOI] [PubMed] [Google Scholar]
  • 99.Fu Q, Yu X, Callaway CW, et al. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J. 2009;23:2438–2449. doi: 10.1096/fj.08-124768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Ke X, Lei Q, James SJ, et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol Genomics. 2006;25:16–28. doi: 10.1152/physiolgenomics.00093.2005. [DOI] [PubMed] [Google Scholar]
  • 101.Morbidelli L, Chang CH, Douglas JG, et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol. 1996;270:H411–415. doi: 10.1152/ajpheart.1996.270.1.H411. [DOI] [PubMed] [Google Scholar]

RESOURCES